Below are the full results of the UK Athletics Anti-doping Programme to date:
|
|
In-competition (1) |
Out-of-competition
|
|
|
|
|
Number of events |
Number of samples (2) |
Number of Samples (3) |
Anti-doping rule violations by UK athletes from samples collected in the UK/ UKA programme (4) (5) |
Anti-doping rule violations by UK athletes from all samples collected |
|
Q4 Jan-Mar 2004 |
8 |
92 |
113 |
0 |
0 |
|
Q1 Apr-Jun 2004 |
7 |
66 |
133 |
1 |
0 |
|
Q2 Jul-Sep 2004 |
6 |
110 |
135 |
0 |
2 |
|
Q3 Oct-Dec 2004 |
0 |
0 |
101 |
0 |
0 |
|
Q4 Jan-Mar 2005 |
6 |
85 |
114 |
0 |
1 |
|
Q1 Apr-Jun 2005 |
8 |
66 |
119 |
0 |
0 |
|
Q2 Jul-Sep 2005 |
9 |
138 |
37 |
0 |
0 |
|
Q3 Oct-Dec 2005 |
2 |
14 |
138 |
0 |
0 |
|
Q4 Jan-Mar 2006 |
9 |
102 |
103 |
0 |
0 |
|
Q1 Apr-Jun 2006 |
5 |
55 |
79 |
0 |
0 |
|
Q2 Jul-Sep 2006 |
8 |
128 |
93 |
1 |
0 |
|
Q3 Oct-Dec 2006 |
2 |
13 |
73 |
0 |
0 |
|
Q4 Jan-Mar 2007 |
7 |
187 |
62 |
0 |
0 |
|
Q1 Apr-Jun 2007 |
6 |
67 |
27 |
0 |
0 |
|
Q2 Jul-Sep 2007 |
10 |
134 |
33 |
1 |
0 |
|
Q3 Oct-Dec 2007 |
2 |
10 |
93 |
0 |
0 |
|
Q4 Jan-Mar 2008 |
9 |
96 |
120 |
0 |
0 |
|
Q1 Apr-Jun 2008 |
8 |
59 |
169 |
0 |
0 |
|
Q2 Jul-Sep 2008 |
7 |
154 |
138 |
0 |
0 |
|
Q3 Oct-Dec 2008 |
3 |
20 |
87 |
0 |
0 |
|
Q4 Jan-Mar 2009 |
6 |
76 |
46 |
0 |
0 |
|
Q1 Apr-Jun 2009 |
8 |
70 |
43 |
0 |
0 |
|
Q2 Jul-Sep 2009 |
6 |
117 |
52 |
0 |
0 |
|
Q3 Oct-Dec 2009 |
3 |
37 |
85 |
0 |
0 |
|
Q4 Jan-Mar 2010 |
7 |
72 |
99 |
3 |
0 |
|
Q1 Apr-Jun 2010 |
8 |
113 |
47 |
1 |
0 |
|
Q2 Jul-Sep 2010 |
8 |
72 |
89 |
0 |
0 |
|
Q3 Oct-Dec 2010 |
2 |
20 |
78 |
0 |
0 |
|
Q4 Jan-Mar 2011 |
6 |
79 |
71 |
0 |
0 |
|
Q1 Apr-Jun 2011 |
9 |
74 |
73 |
0 |
0 |
|
Q2 Jul-Sep 2011 |
7 |
125 |
41 |
0 |
0 |
|
Notes |
|
|
|
|
|
|
(1) Figures refer to samples collected by UK Sport/ UKAD at athletics competitions in the UK as part of the UKA/ IAAF/ EAA doping programmes |
|
(2) Figures refer to the number of samples collected from British and International athletes. Please note that more that one sample may be provided from an athlete during the quarter. |
|
(3) Figures refer to samples collected from UK athletes as part of the out-of-competition testing programme. Includes samples collected from UK athletes abroad as part of the UK programme. |
|
(4) Not including findings where a prior Therapeutic Use Exemption has been obtained by the athlete. Findings from tests conducted in the UK and abroad as part of the UK programme and tests in-competition in the UK. |
|
(5) Only includes cases which have been concluded and which have resulted in an Anti-Doping Rule Violation. |